Expression of p53 in epithelial ovarian tumors

被引:4
|
作者
Amanullah, Nihad Abdul Razak [1 ]
Poothiode, Usha [2 ]
Vilasiniamma, Letha [3 ]
机构
[1] Imam Abdulrahman Bin Faisal Univ, Pathol, Dept Neurosci Technol, Coll Appl Med Sci Jubail CAMSJ, POB 3856, Jubail Ind City, Al Jubail, Saudi Arabia
[2] Kerala Univ Hlth Sci, Dept Pathol, Malankara Orthodox Syrian Church Med Coll, Trichur, Kerala, India
[3] Kerala Univ Hlth Sci, Dept Pathol, Govt Med Coll Kottayam, Trichur, Kerala, India
关键词
Epithelial ovarian tumors; high-grade serous carcinoma; IHC; p53; PROGNOSTIC IMPORTANCE; SEROUS CARCINOMAS; LOW-GRADE; STAGE; MUTATION; OVEREXPRESSION; BENIGN; CANCER; CA-125;
D O I
10.4103/IJPM.IJPM_526_19
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Ovarian cancers remain the most lethal of all gynecological malignancies despite major developments in their treatment. Objectives: To study the rate of expression and staining patterns of p53 in various histological types and grades of epithelial ovarian tumors (EOT). Materials and Methods: Sixty EOTs received in a tertiary care center were studied for gross, microscopy, and p53 immunohistochemistry (IHC) expression patterns. Parameters such as age, laterality of tumor, ascites, capsule rupture, tumor size, stage at presentation, metastasis, tumor grade, and number of mitosis were correlated. Results: Of the sixty cases studied, 23 (38.3%) were malignant. Serous carcinomas were the largest group with 17 cases (74%) followed by mucinous with 4 cases (17%) and 2 clear cell carcinomas (9%). All benign and borderline EOT were p53 negative. 65.2% of the malignancies were p53 positive and all of them were serous malignancies. 15 out of 16 high-grade serous carcinomas were p53 positive (94%), while one case was negative (6%). 10 cases (63%) showed intense diffuse positivity of more than 60% of the nucleus, while 5 cases (31%) showed aberrant null staining <5% staining of the nucleus. All mucinous, clear cell carcinomas, and the only low-grade serous carcinoma in the study were p53 negative. P53 staining had positive correlations with variables like capsule rupture, ascites, laterality, and CA 125. Conclusions: The study highlights the different rates of expression and staining patterns of p53 and the need for correct interpretation of p53 IHC for the diagnosis of various EOT.
引用
下载
收藏
页码:235 / 240
页数:6
相关论文
共 50 条
  • [1] P53 EXPRESSION IN OVARIAN EPITHELIAL STROMAL TUMORS
    COSTA, I
    MATIASGUIU, X
    MUSULEN, E
    CUATRECASAS, M
    PRAT, J
    LABORATORY INVESTIGATION, 1995, 72 (01) : A88 - A88
  • [2] Expression of p53 in epithelial ovarian cancer
    Ozalp, S
    Yalcin, OT
    Minsin, TH
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 (03) : 277 - 278
  • [3] P53 PROTEIN OVEREXPRESSION IN OVARIAN EPITHELIAL TUMORS
    OREILLY, PE
    PARK, HK
    FINLEY, JL
    LABORATORY INVESTIGATION, 1994, 70 (01) : A93 - A93
  • [5] HPV and p53 expression in epithelial ovarian carcinoma
    Kuscu, E
    Ozdemir, BH
    Erkanli, S
    Haberal, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (06) : 642 - 645
  • [6] p53 Protein expression and p53 mutation in thymic epithelial tumors - Reply
    Tateyama, H
    Eimoto, T
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (05) : 658 - 658
  • [7] p53 protein expression in thymic epithelial tumors
    Hino, N
    Kondo, K
    Miyoshi, T
    Uyama, T
    Monden, Y
    EPITHELIAL TUMORS OF THE THYMUS: PATHOLOGY, BIOLOGY, TREATMENT, 1997, : 41 - 45
  • [8] Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors
    Lee, W. S.
    Park, E. S.
    Kim, D. H.
    Kim, T. H.
    Lee, H. H.
    Chung, S. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (04) : 358 - 362
  • [9] Expression of p53 protein in borderline epithelial ovarian tumors: a clinicopathologic study of 39 cases
    Darai, E
    Walker-Combrouze, F
    Mlika-Cabanne, N
    Feldmann, G
    Madelenat, P
    Scoazec, JY
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (02) : 144 - 149
  • [10] Correlation of TP53 mutations and p53 expression in ovarian tumors
    DiCioccio, RA
    Werness, BA
    Peng, RQ
    Allen, HJ
    Piver, MS
    CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) : 93 - 102